- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| CORNERSTONE THERAPEUTICS Aktie jetzt für 0€ handeln |
0 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| GILEAD SCIENCES | 135,54 | -0,86 % | BofA hebt Kursziel für Gilead Sciences nach positiven Studiendaten an | ||
| ZOETIS | 70,84 | -0,03 % | Zoetis: FDA-Erfolg - diese Warnung zählt jetzt | ||
| INCYTE | 103,00 | +1,98 % | 17 Prozent Kursverlust nach Studienflop: Syndax stoppt Entwicklung - Mesoblast setzt auf den nächsten GvHD-Markt | ||
| AMARIN | 9,950 | -3,40 % | Amarin Corporation plc: Amarin Reports 2026 Second Quarter Financial Results Demonstrating Early Success of Fully Partnered International Commercial Strategy and Continued Leading U.S. Market Presence | Q2 2026 Results Highlight Global Volume Growth, Lower Operating Expenses and Positive Cash Flow For Full Year 2026, Company Expects Continued Growth in International Markets, Maintenance of VASCEPA's... ► Artikel lesen | |
| FILANA THERAPEUTICS | 0,618 | +5,28 % | FILANA THERAPEUTICS, INC. - 8-K, Current Report | ||
| LIGAND PHARMACEUTICALS | 260,00 | -7,14 % | Ligand Pharmaceuticals: Ligand to Report Third Quarter 2026 Financial Results on October 29, 2026 | ||
| ACHIEVE LIFE SCIENCES | 5,800 | 0,00 % | Achieve Life Sciences Presents 52-Week Cytisinicline Results for Smoking and Vaping Cessation at CHEST 2026 | ||
| MADRIGAL PHARMACEUTICALS | 421,90 | +3,46 % | Madrigal Pharmaceuticals, Inc.: Madrigal Pharmaceuticals Reports Second-Quarter 2026 Financial Results and Provides Corporate Updates | Second-quarter 2026 Rezdiffra- (resmetirom) net sales of $364.3 million, representing year-over-year growth of 71% As of June 30, 2026, more than 49,000 patients on Rezdiffra, more than doubling... ► Artikel lesen | |
| ANI PHARMACEUTICALS | 65,00 | +0,78 % | ANI Pharmaceuticals bringt Duloxetin-Generikum auf den Markt | ||
| TALPHERA | 0,960 | +3,23 % | Talphera, Inc.: Talphera Announces First Quarter 2026 Financial Results and Provides Corporate Update | NEPHRO CRRT clinical study expected to be completed this year
Cash and investments of $21.1 million at March 31, 2026
Conference call and webcast to be held on Wednesday... ► Artikel lesen | |
| RIGEL PHARMACEUTICALS | 42,300 | +1,90 % | Rigel Pharmaceuticals, Inc.: Rigel Reports Second Quarter 2026 Financial Results | Second quarter 2026 total revenues of $78.7 million, including net product sales of $67.0 million and contract revenues from collaborations of $11.7 million, and... ► Artikel lesen | |
| SAVARA | 4,034 | -2,87 % | Savara Inc.: Savara Announces Encore Presentations of Results from the Phase 3 Clinical Trial of Molgramostim Inhalation Solution (Molgramostim) in Autoimmune Pulmonary Alveolar Proteinosis (APAP) at the European Respiratory Society (ERS) Congress 2026 | -- Company to Host Industry Evening Mini-Symposium on aPAP with Renowned Key Opinion Leaders --Savara Inc. (Nasdaq: SVRA), a clinical stage biopharmaceutical company focused on rare respiratory diseases... ► Artikel lesen | |
| ARTIVION | 20,200 | -0,98 % | Artivion, Inc.: Artivion Reports Second Quarter 2026 Financial Results | Second Quarter & Recent Business Highlights:
Achieved revenue of $125.8 million in the second quarter of 2026 versus $113.0 million in the second quarter of 2025... ► Artikel lesen | |
| BIODEXA PHARMACEUTICALS | 0,420 | 0,00 % | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 02.10.2026 -4- | The following instruments on Boerse Frankfurt do have their last trading day on 02.10.2026Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 02.10.2026ISIN NameUS1509643029 CENNTRO... ► Artikel lesen | |
| HERON THERAPEUTICS | 0,313 | 0,00 % | Heron Therapeutics, Inc.: U.S. District Court Issues Decision Regarding CINVANTI Patents | CARY, N.C., June 02, 2026 (GLOBE NEWSWIRE) -- Heron Therapeutics, Inc. (Nasdaq: HRTX) ("Heron" or the "Company"), a commercial-stage biotechnology company, today announced that the U.S. District Court... ► Artikel lesen |
CORNERSTONE THERAPEUTICS INC gehört der Branche Pharma an.
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu CORNERSTONE THERAPEUTICS INC finden Sie auf Wallstreet Online.